BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 27777022)

  • 21. Retinal Imaging Findings in Carriers With PSEN1-Associated Early-Onset Familial Alzheimer Disease Before Onset of Cognitive Symptoms.
    Armstrong GW; Kim LA; Vingopoulos F; Park JY; Garg I; Kasetty M; Silverman RF; Zeng R; Douglas VP; Lopera F; Baena A; Giraldo M; Norton D; Cronin-Golomb A; Arboleda-Velasquez JF; Quiroz YT; Miller JB
    JAMA Ophthalmol; 2021 Jan; 139(1):49-56. PubMed ID: 33180114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.
    Gordon BA; Blazey TM; Su Y; Hari-Raj A; Dincer A; Flores S; Christensen J; McDade E; Wang G; Xiong C; Cairns NJ; Hassenstab J; Marcus DS; Fagan AM; Jack CR; Hornbeck RC; Paumier KL; Ances BM; Berman SB; Brickman AM; Cash DM; Chhatwal JP; Correia S; Förster S; Fox NC; Graff-Radford NR; la Fougère C; Levin J; Masters CL; Rossor MN; Salloway S; Saykin AJ; Schofield PR; Thompson PM; Weiner MM; Holtzman DM; Raichle ME; Morris JC; Bateman RJ; Benzinger TLS
    Lancet Neurol; 2018 Mar; 17(3):241-250. PubMed ID: 29397305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease.
    Almkvist O; Johansson C; Laffita-Mesa J; Thordardottir S; Graff C
    Eur J Neurol; 2022 Dec; 29(12):3580-3589. PubMed ID: 36039401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene mutations associated with early onset familial Alzheimer's disease in China: An overview and current status.
    Qin Q; Yin Y; Wang Y; Lu Y; Tang Y; Jia J
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1443. PubMed ID: 32767553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing a Gene Therapy for the Treatment of Autosomal Dominant Alzheimer's Disease.
    Moore B; Sharma A; Goulet M; Suter T; Pelletier C; Hu R; Schaeffer E; Kelleher RJ
    Hum Gene Ther; 2023 Oct; 34(19-20):1049-1063. PubMed ID: 37578141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.
    An SS; Park SA; Bagyinszky E; Bae SO; Kim YJ; Im JY; Park KW; Park KH; Kim EJ; Jeong JH; Kim JH; Han HJ; Choi SH; Kim S
    Clin Interv Aging; 2016; 11():1817-1822. PubMed ID: 28008242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
    Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
    Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seizures in dominantly inherited Alzheimer disease.
    Zarea A; Charbonnier C; Rovelet-Lecrux A; Nicolas G; Rousseau S; Borden A; Pariente J; Le Ber I; Pasquier F; Formaglio M; Martinaud O; Rollin-Sillaire A; Sarazin M; Croisile B; Boutoleau-Bretonnière C; Ceccaldi M; Gabelle A; Chamard L; Blanc F; Sellal F; Paquet C; Campion D; Hannequin D; Wallon D;
    Neurology; 2016 Aug; 87(9):912-9. PubMed ID: 27466472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early-onset familial Alzheimer's disease (EOFAD).
    Wu L; Rosa-Neto P; Hsiung GY; Sadovnick AD; Masellis M; Black SE; Jia J; Gauthier S
    Can J Neurol Sci; 2012 Jul; 39(4):436-45. PubMed ID: 22728850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.
    Campion D; Dumanchin C; Hannequin D; Dubois B; Belliard S; Puel M; Thomas-Anterion C; Michon A; Martin C; Charbonnier F; Raux G; Camuzat A; Penet C; Mesnage V; Martinez M; Clerget-Darpoux F; Brice A; Frebourg T
    Am J Hum Genet; 1999 Sep; 65(3):664-70. PubMed ID: 10441572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.
    Raux G; Guyant-Maréchal L; Martin C; Bou J; Penet C; Brice A; Hannequin D; Frebourg T; Campion D
    J Med Genet; 2005 Oct; 42(10):793-5. PubMed ID: 16033913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.
    Scahill RI; Ridgway GR; Bartlett JW; Barnes J; Ryan NS; Mead S; Beck J; Clarkson MJ; Crutch SJ; Schott JM; Ourselin S; Warren JD; Hardy J; Rossor MN; Fox NC
    J Alzheimers Dis; 2013; 35(1):199-212. PubMed ID: 23380992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic counseling and testing for families with Alzheimer's disease].
    Kowalska A
    Neurol Neurochir Pol; 2004; 38(6):495-501. PubMed ID: 15654674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
    Reiman EM; Quiroz YT; Fleisher AS; Chen K; Velez-Pardo C; Jimenez-Del-Rio M; Fagan AM; Shah AR; Alvarez S; Arbelaez A; Giraldo M; Acosta-Baena N; Sperling RA; Dickerson B; Stern CE; Tirado V; Munoz C; Reiman RA; Huentelman MJ; Alexander GE; Langbaum JB; Kosik KS; Tariot PN; Lopera F
    Lancet Neurol; 2012 Dec; 11(12):1048-56. PubMed ID: 23137948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presenilin 1 and APP Gene Mutations in Early-Onset AD Families from a Southeast Region of China.
    Zhou J; Chen Y; Meng F; Zhang K; Liu X; Peng G
    Curr Alzheimer Res; 2020; 17(6):540-546. PubMed ID: 32579498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
    Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
    Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid beta precursor protein and presenilin genes in Colombia.
    Arango D; Cruts M; Torres O; Backhovens H; Serrano ML; Villareal E; Montañes P; Matallana D; Cano C; Van Broeckhoven C; Jacquier M
    Am J Med Genet; 2001 Oct; 103(2):138-43. PubMed ID: 11568920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer's Disease.
    Yang Y; Bagyinszky E; An SSA
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.
    Larner AJ; Doran M
    J Neurol; 2006 Feb; 253(2):139-58. PubMed ID: 16267640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.